Globus said it will offer 33 unique itineraries to Italy in 2025, covering 13 regions, 99 cities and several travel styles.
Jefferies analyst Matthew Taylor maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...
Morgan Stanley analyst Kallum Titchmarsh maintained a Buy rating on Globus Medical (GMED – Research Report) on January 8 and set a price target ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Hosted on MSN2d
B of A Securities Upgrades Globus Medical (GMED)Fintel reports that on January 9, 2025, B of A Securities upgraded their outlook for Globus Medical (NYSE:GMED) from Underperform to Neutral. Analyst Price Forecast Suggests 12.50% Upside As of ...
Audubon, PA-based Globus Medical, Inc. is a medical device ... Additionally, the company could be a top pick for growth investors. GMED has a Growth Style Score of A, forecasting year-over-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback